Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » Mark Baker on Proteomics in Australia and How He Got Into the Field

Mark Baker on Proteomics in Australia and How He Got Into the Field

Aug 06, 2004
Premium

At A Glance

Name: Mark Baker

Position: CEO, Australian Proteome Analysis Facility, Sydney, since 2003

Professor of Proteomics, Macquarie University, Sydney, since 2003

Background: Director of Biomarker Discovery, LumiCyte, 2001-2003

Foundation Director, Gynaecological Cancer Research Center, Melbourne, 1998-2001

Associate Professor, University of Melbourne, 1998-2001

Associate Professor, University of Wollongong, Australia, 1992-1998

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Millions of Tests

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Court Pick and Science

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Arthur Ashkin Dies

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

PNAS Papers on Alzheimer's Transcriptomes, Bladder Cancer Mutations, CRC Drivers

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.

Oct
14
Featured Webinar

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

Sponsored by
Inivata

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

What's Popular?

In Proteomics & Protein Research

  1. Alzheimer's Disease Linked to Epigenetic Changes in Multi-Omic Study

  2. Genosity, Olink Proteomics Ink Strategic Collaboration

  3. Ionpath Expanding Sales Force, Investing in Informatics Tools Development

    Premium

  4. Ionpath Closes $18M Series B Round

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.